Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics

S Qin, W Xiao, C Zhou, Q Pu, X Deng, L Lan… - Signal transduction and …, 2022 - nature.com
Pseudomonas aeruginosa (P. aeruginosa) is a Gram-negative opportunistic pathogen that
infects patients with cystic fibrosis, burn wounds, immunodeficiency, chronic obstructive …

Protein cages: from fundamentals to advanced applications

TGW Edwardson, MD Levasseur, S Tetter… - Chemical …, 2022 - ACS Publications
Proteins that self-assemble into polyhedral shell-like structures are useful molecular
containers both in nature and in the laboratory. Here we review efforts to repurpose diverse …

CRISPR-based technologies for the manipulation of eukaryotic genomes

AC Komor, AH Badran, DR Liu - Cell, 2017 - cell.com
The CRISPR-Cas9 RNA-guided DNA endonuclease has contributed to an explosion of
advances in the life sciences that have grown from the ability to edit genomes within living …

Adenovirus-mediated gene delivery: potential applications for gene and cell-based therapies in the new era of personalized medicine

CS Lee, ES Bishop, R Zhang, X Yu, EM Farina, S Yan… - Genes & diseases, 2017 - Elsevier
With rapid advances in understanding molecular pathogenesis of human diseases in the era
of genome sciences and systems biology, it is anticipated that increasing numbers of …

Screening and large-scale expression of membrane proteins in mammalian cells for structural studies

A Goehring, CH Lee, KH Wang, JC Michel… - Nature protocols, 2014 - nature.com
Structural, biochemical and biophysical studies of eukaryotic membrane proteins are often
hampered by difficulties in overexpression of the candidate molecule. Baculovirus …

[HTML][HTML] Viral and nonviral delivery systems for gene delivery

N Nayerossadat, T Maedeh, PA Ali - Advanced biomedical …, 2012 - journals.lww.com
Gene therapy is the process of introducing foreign genomic materials into host cells to elicit
a therapeutic benefit. Although initially the main focus of gene therapy was on special …

Recent advances in lentiviral vector development and applications

J Mátrai, MKL Chuah, T VandenDriessche - Molecular therapy, 2010 - cell.com
Lentiviral vectors (LVs) have emerged as potent and versatile vectors for ex vivo or in vivo
gene transfer into dividing and nondividing cells. Robust phenotypic correction of diseases …

Spike glycoprotein and host cell determinants of SARS-CoV-2 entry and cytopathic effects

HT Nguyen, S Zhang, Q Wang, S Anang… - Journal of …, 2021 - Am Soc Microbiol
ABSTRACT SARS-CoV-2, a betacoronavirus, is the cause of the COVID-19 pandemic. The
SARS-CoV-2 spike (S) glycoprotein trimer mediates virus entry into host cells and cytopathic …

Inhibition of microRNA-29b reduces murine abdominal aortic aneurysm development

L Maegdefessel, J Azuma, R Toh… - The Journal of …, 2012 - Am Soc Clin Investig
MicroRNAs (miRs) regulate gene expression at the posttranscriptional level and play crucial
roles in vascular integrity. As such, they may have a role in modifying abdominal aortic …

[HTML][HTML] Gene therapy in the anterior eye segment

C Amador, R Shah, S Ghiam, AA Kramerov… - Current gene …, 2022 - ncbi.nlm.nih.gov
This review provides comprehensive information about the advances in gene therapy in the
anterior segment of the eye, including cornea, conjunctiva, lacrimal gland, and trabecular …